CAMD Public Presentations

Advancement of AD biomarkers for qualification: the regulatory path

ADNI PPSB, April 2012
Stephenson D

Qualifying New Science in Drug Development: Essential Role of Standards

ACRP Global Conference, April 2012
Neville J

Critical Path Institute: The role of Patient Advocacy groups in accelerating drug development

Oral presentation at the CALBIO2012 Meeting, March 2012
Stephenson D

Critical Path Institute: The role of Patient Advocacy groups in accelerating drug development

Sanofi R&D Directors Meeting, Partners in Patient Health, March 2012
Stephenson D

AD Biomarkers: Regulatory Science Path

Research Alzheimer's Disease Standardization Meeting, Melbourne, March 2012
Stephenson D

"Avoiding consortium fatigue: lessons learned from Critical Path Institute"

HRA webinar, February 2012
Hudson L, Stephenson D

Tucson Breakfast Club: Celebrating the Alzheimer's Strategy

The Critical Path, February 2012
Stephenson D

The silent crisis in healthcare: Tucson's unique response

Pima Community Council in Aging, January 2012
Woosley R

Partnerships for Creating Consensus Science in Drug Development

NMSS Task Force, December 2011
Hudson L, Stephenson D

Biomarkers as Drug Development tools

Creating Consensus Meeting, December 2011
Romano G

Lunch and Learn: Celebrating the Alzheimer's Strategy

The Critical Path, November 2011
Stephenson D

"Collaboration: Secrets of Success."

FasterCuresPartnering for Cures, November 2011
Avilés E; Harvey B

Lunch and Learn: Celebrating the Alzheimer's Strategy

The Critical Path, November 2011
Stephenson D

Data Sharing Collaboratives

IOM Science on Neuroscience and Nervous System Disorders,
August 2011
Hudson L

Alzheimer's Disease Therapeutic-area Standards Development: A collaborative effort between CDISC and the Critical Path Institute

DIA Annual Meeting, June 2011
Neville J